Chandan Adhikari

Chandan Adhikari

Auto-generated profile, based on publicly available information

Chandan Adhikari

University of Engineering & Management

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

7 July 2021 in Polymer-Plastics Technology and Materials
Verified
Journal Article
Closed access
CAChandan Adhikari
Chandan Adhikari
Nanosized particles have appealing attributes, which have gotten impressive consideration in the last few decades. Polymeric nanoparticles (PNP)s are particles or particulate materials with size at least in the range of 10–100 nm in one dimension. Due to the extremely small size, high volume-surface area ratio, tunable pore, polymer nanoparticles have been used for various applications in different fields,for example, in drug delivery, biosensors, stimuli responsive cargo delivery, nanocomposites, agricultural and environmental applications. The recent development of incorporation of inorganic nanoparticles to polymers permits the alteration of the polymer’s physical as well as chemical properties just as the execution of new highlights in the polymer network. Conjugated polymer nanoparticles are profoundly flexible nano-organized materials that can conceivably discover applications in different branches of science and engineering, for example, optoelectronics, photonics, bio-imaging, bio-detecting and nanomedicine. Their desired sizes and unique properties, biocompatibility and low-toxicity make these materials profoundly appealing for the previously mentioned applications. Polymeric nanoparticles (NPs) are one of the most used nanomaterials for application in nanomedicine. Extreme intrigue lies in the capability of polymeric NPs to alter present-day medication. Usages of polymeric NPs incorporate medication delivery, for example, conjugation and entanglement of medications, prodrugs, stimuli responsive systems, imaging modalities, and theranostics. Biodegradable polymeric nano-structures (BPN) have indicated extraordinary guarantee in various remedial applications, for example, analysis, imaging, sedate delivery, beautifying agents, organ embeds and tissue designing. BPNs display better properties over their separate bulk materials, conquering the restrictions of customary polymers to address numerous significant clinical issues. Besides, the recent developments in research in various area of polymers can empower explicit functionalities of the polymeric nanostructures to be balanced for tunable applications. This concise review emphasizes the various preparative methods of polymeric nanoparticles developed in the last few decades and their uses in various branches of science, e.g., therapeutic, optoelectronic, catalytic and magnetic applications along with several challenging issues concerning the commercialization of emerging polymer-based therapeutics. It also comments on the futuristic uses and applications of polymer nanoparticles in various fields of science in coming decades. GRAPHICAL ABSTRACT


19 May 2015 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
RTRaina Thakur
Raina Thakur
ADAnupam Das
Anupam Das
VSVandna Sharma
Vandna Sharma
CAChandan Adhikari
Chandan Adhikari
KGKalyan Sundar Ghosh
Kalyan Sundar Ghosh
ACAnjan Chakraborty
Anjan Chakraborty
Studies on interactions between an anticancer alkaloid, ellipticine, and various carrier proteins in blood serum show tangible results to gain insight into the solubility and transport of the drug under physiological conditions. In this report, we extensively studied the interactions of different prototropic species of ellipticine with two prominent serum proteins namely human serum albumin (HSA) and immunoglobulin G (IgG) in their native and partially unfolded states using steady state and time resolved fluorescence spectroscopy, molecular docking and circular dichroism (CD). Both the fluorescence techniques and molecular modeling studies elucidate that only neutral species of ellipticine binds to HSA in the sudlow site II. Unlike HSA, IgG in the native state mostly binds to cationic species of ellipticine. However, in partially unfolded configuration, IgG binds to the neutral ellipticine molecules. Molecular docking studies indicate the prevalence of electrostatic interactions involving charged residues in the binding process of cationic species of ellipticine with native IgG in its Fab region. In native conformation, the hydrophobic residues of the Fab region are found to be buried completely by the ligand. This implies that the hydrophobic interaction will be favored by unfolding of IgG through which the hydrophobic pocket will be more accessible to neutral species of ellipticine. The circular dichroism measurements reveal that upon interaction with ellipticine, heat and acid treated HSA resumes its α-helical content. This conclusive comparative study on interactions of IgG and HSA with ellipticine yields the result that native HSA is responsible for transport of neutral species of ellipticine whereas IgG carries cationic ellipticine in its native form.

1 October 2018 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
CAChandan Adhikari
Chandan Adhikari
AMAnurag Ramsuman Mishra
Anurag Ramsuman Mishra
DNDebasis Nayak
Debasis Nayak
ACAnjan Chakraborty
Anjan Chakraborty

1 April 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SVShinde Vidyacharan
Shinde Vidyacharan
CAChandan Adhikari
Chandan Adhikari
VKVagolu Siva Krishna
Vagolu Siva Krishna
RRRudraraju Srilakshmi Reshma
Rudraraju Srilakshmi Reshma
DSDharmarajan Sriram
Dharmarajan Sriram
DSDuddu S. Sharada
Duddu S. Sharada